Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fresh Microglia Destroy Alzheimer's Plaques

By Biotechdaily staff writers
Posted on 12 Mar 2006
Researchers have found that microglia, the specialized immune cells of the nervous system, were effective in destroying the amyloid plaques of Alzheimer's disease if they were recently derived from bone marrow stem cells, but not if they were long-term residents of the brain.

Investigators at the faculty of medicine of Université Laval (Quebec, CA) worked with a transgenic mouse model of human Alzheimer's disease. More...
They showed that in contrast to resident microglia, similar cells transferred from the bone marrow to the brain became highly branched and elongated within the core of amyloid plaques. Further results published in the February 16, 2006, issue of Neuron revealed that the microglia's phagocytic action dissolved the plaques.
"Stem cells should be harvested from the patients themselves, thus limiting the risks of both rejection and adverse effects,” said senior author Dr. Serge Rivest, professor of molecular endocrinology at Université Laval. "While this cellular therapy will not prevent Alzheimer's, by curbing plaque development, we believe that it will help patients prolong their autonomy and cognitive capacity. We believe that this is a new and powerful weapon in the fight to conquer Alzheimer's.”


Related Links:
Université Laval

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
HPV Test
Allplex HPV28 Detection
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.